Structures by: Wang S. F.
Total: 22
C20H30O2,0.5(C2H3N)
C20H30O2,0.5(C2H3N)
Journal of natural products (2015) 78, 5 1037-1044
a=6.3147(2)Å b=23.2682(9)Å c=25.4495(11)Å
α=90.00° β=90.00° γ=90.00°
C30H48O4
C30H48O4
Journal of natural products (2015) 78, 5 1037-1044
a=9.4572(3)Å b=7.77569(19)Å c=19.2277(5)Å
α=90° β=103.188(3)° γ=90°
C20H28O2
C20H28O2
Journal of natural products (2015) 78, 5 1037-1044
a=12.4345(4)Å b=6.06696(15)Å c=12.7077(4)Å
α=90° β=115.588(4)° γ=90°
C16H12ClN3O
C16H12ClN3O
Organic & biomolecular chemistry (2013) 11, 37 6328-6337
a=15.8817(11)Å b=5.8250(4)Å c=16.5782(12)Å
α=90.00° β=117.321(2)° γ=90.00°
Wx-4
C13H12N2O2
Organic & biomolecular chemistry (2014) 12, 45 9157-9165
a=8.7007(12)Å b=15.1805(19)Å c=8.6860(10)Å
α=90.00° β=104.082(4)° γ=90.00°
C12H15DyO9P3
C12H15DyO9P3
Dalton Transactions (2020)
a=9.0836(8)Å b=9.4719(8)Å c=12.1265(10)Å
α=67.642(2)° β=70.658(2)° γ=64.713(2)°
C12H15HoO9P3
C12H15HoO9P3
Dalton Transactions (2020)
a=9.0404(3)Å b=9.4303(3)Å c=12.0760(4)Å
α=67.7680(10)° β=70.814(2)° γ=64.9800(10)°
C12H15O9P3Tb
C12H15O9P3Tb
Dalton Transactions (2020)
a=9.0909(5)Å b=9.4752(4)Å c=12.1186(6)Å
α=67.655(2)° β=70.568(3)° γ=64.578(2)°
Salicylideneacetone
C10H10O2
Acta Crystallographica Section E (2005) 61, 6 o1697-o1698
a=7.3500(15)Å b=7.4900(15)Å c=8.8100(18)Å
α=97.05(3)° β=95.86(3)° γ=115.34(3)°
1-(5-(4-hydroxy-3-methoxyphenyl)-3-methyl-4,5-dihydropyrazol-1-yl)-ethanone
C13H16N2O3
Acta Crystallographica Section E (2005) 61, 12 o3985-o3986
a=7.5862(6)Å b=10.5414(9)Å c=15.6452(13)Å
α=90.00° β=102.9130(10)° γ=90.00°
(E)-4-(4-hydroxy-3-methoxyphenyl) but-3-en-2-one
C11H12O3
Acta Crystallographica Section E (2006) 62, 3 o871-o872
a=9.602(5)Å b=7.780(4)Å c=13.478(7)Å
α=90.00° β=97.466(8)° γ=90.00°
1,4,8,11-Tetrakis(carboxymethyl)-5,5,7,12,12,14-hexamethyl-1,4,8,11- tetraazoniacyclotetradecane tetrachloride octahydrate
C24H48N4O84,4Cl,8H2O
Acta Crystallographica Section E (2005) 61, 8 o2413-o2414
a=8.6283(3)Å b=10.6995(4)Å c=11.0065(4)Å
α=100.1610(10)° β=94.4820(10)° γ=103.1680(10)°
(5,5,7,12,12,14-Hexamethyl-1,4,8,11-tetraazacyclotetradecane-1,8- diacetato)nickel(II) tetrahydrate
C20H38N4O4Ni,4H2O
Acta Crystallographica Section E (2005) 61, 8 m1481-m1483
a=9.1863(6)Å b=13.8653(9)Å c=19.9870(10)Å
α=90.00° β=93.6040(10)° γ=90.00°
(5,5,7,12,12,14-Hexamethyl-1,4,8,11-tetraazacyclotetradecane-1,8- diacetato)cobalt(II) tetrahydrate
C20H38CoN4O4,4H2O
Acta Crystallographica Section E (2005) 61, 8 m1484-m1485
a=9.1896(6)Å b=13.8731(9)Å c=20.0010(10)Å
α=90.00° β=93.6410(10)° γ=90.00°
1,4,8,11-Tetrakis(carboxymethyl)-5,5,7,12,12,14-hexamethyl- 4,11-diaza-1,8-diazoniacyclotetradecane dichloride dihydrate
C24H46N4O82,2(Cl),2(H2O)
Acta Crystallographica Section E (2008) 64, 5 o885
a=9.977(5)Å b=13.475(7)Å c=11.572(6)Å
α=90.00° β=104.220(9)° γ=90.00°
Bis[2-(1,3-dioxoisoindolin-2-yl)ethyl] phthalate
C28H20N2O8
Acta Crystallographica Section E (2010) 66, 2 o337
a=15.021(2)Å b=12.3953(19)Å c=25.954(4)Å
α=90.00° β=90.125(2)° γ=90.00°
Ethyl 3-methyl-4-oxo-4,5-dihydro-1<i>H</i>- pyrrolo[2,3-<i>d</i>]pyridazine-2-carboxylate
C10H11N3O3
Acta Crystallographica Section E (2010) 66, 2 o259
a=8.0030(16)Å b=9.774(2)Å c=13.370(3)Å
α=90.00° β=90.17(3)° γ=90.00°
Tetraethyl 1,1'-(ethane-1,2-diyl)bis(2,5-dimethyl-1<i>H</i>-pyrrole-3,4-dicarboxylate)
C26H36N2O8
Acta Crystallographica Section E (2010) 66, 12 o3047
a=12.891(3)Å b=13.743(3)Å c=16.717(3)Å
α=90.00° β=113.350(14)° γ=90.00°
C17H16F3N4O2Pt0.5
C17H16F3N4O2Pt0.5
ACS applied materials & interfaces (2020)
a=13.6532(4)Å b=7.2160(2)Å c=18.2271(5)Å
α=90° β=101.2112(9)° γ=90°
C20H20F6N8Pt
C20H20F6N8Pt
ACS applied materials & interfaces (2020)
a=5.4881(4)Å b=17.5940(12)Å c=11.4063(8)Å
α=90° β=96.767(2)° γ=90°
C19H15F6N7Pt
C19H15F6N7Pt
ACS applied materials & interfaces (2020)
a=11.9498(2)Å b=9.2290(2)Å c=18.3551(4)Å
α=90° β=93.5512(5)° γ=90°
Acetato-μ-N,N-bis(salicylidene)-3-methyl-3-aza-1,5-pentanediaminocobalt(III)
C23H28CoN3O4
Zeitschrift für Kristallographie - New Crystal Structures (2006) 221, 3 409-410
a=9.400(4)Å b=19.203(5)Å c=12.112(5)Å
α=90.00° β=92.33° γ=90.00°